COVID-19
Nasal swab eluates for COVID-19
Year Started: 2019
Clinical discard specimens in a variety of transport media. Tested positive or negative by USFDA EUA COVID-19 molecular test. Subset of specimens available with Ct values for positives. Up to 250µL available per specimen. Negative pools available for some transport media.
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Human genetic analysis restriction, Scope of use restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | Immediate |
Freezer temperature logs | Immediate |
Genomic datasets | Immediate |
Pre-analytical data | Immediate |
Physiological/biochemical measurements | Immediate |
Undifferentiated
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Microscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Swab medium | -85°C to -60°C | Not applicable |
COVID-19
Longitudinal serum and plasma
Year Started: 2019
Serum and plasma collected at 1, 2, 4, 8, and 14 weeks post COVID-19 clinical diagnosis
- Access:
- Open to applicants
- Type:
- Longitudinal
- Status:
- Completed
- Consent restrictions:
- Human genetic analysis restriction, Scope of use restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | Immediate |
Clinical records | 0 - 3 months |
Followup records | 0 - 3 months |
Freezer temperature logs | Immediate |
Quality indicators | Immediate |
Participant Ethnicity | 0 - 3 months |
Both sexes
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Microscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma (single spun) | -85°C to -60°C | Not applicable | |||
Serum | -85°C to -60°C | Not applicable |